Effects of cocoa extract and dark chocolate on angiotensin-converting enzyme and nitric oxide in human endothelial cells and healthy volunteers-A nutrigenomics perspective

Journal of Cardiovascular Pharmacology

Volumn 57, Issue 1, 2011, Pages 44-50

  Persson, Ingrid A L ^a   Persson, Karin ^a   Hägg, Staffan ^a   Andersson, Rolf G G ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

angiotensin converting enzyme; Cocoa; dark chocolate; genotyping; nitric oxide

Indexed keywords

COCOA EXTRACT; DIPEPTIDYL CARBOXYPEPTIDASE; NITRIC OXIDE; PLANT EXTRACT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CACAO; CONTROLLED STUDY; DARK CHOCOLATE; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GENE DELETION; GENE INSERTION; GENOTYPE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; MALE; NORMAL HUMAN; NUTRIGENOMICS; PRIORITY JOURNAL; RADIOENZYMATIC ASSAY; UMBILICAL VEIN ENDOTHELIAL CELL;

ADULT; CACAO; CARDIOVASCULAR DISEASES; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; FEMALE; GENOTYPE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NITRIC OXIDE; PEPTIDYL-DIPEPTIDASE A; PLANT EXTRACTS; TIME FACTORS; UMBILICAL VEINS;

EID: 78951480214     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3181fe62e3     Document Type: Article

References (46)

1. Buijsse B, Feskens EJM, Kok J, et al. Cocoa intake, blood pressure, and cardiovascular mortality. Arch Intern Med. 2006;166:411-417.
2. Buijsse B, Weikert C, Drogan D, et al. Chocolate consumption in relation to blood pressure and risk of cardiovascular disease in German adults. Eur Heart J. 2010:30.
3. Corti R, Flammer AJ, Hollenberg K, et al. Cocoa and cardiovascular health. Circulation. 2009;119:1433-1441.
4. Galleano M, Oteiza PI, Fraga CG. Cocoa, chocolate and cardiovascular disease. J Cardiovasc Pharmacol. 2009;54:483-490.
5. Janszky I, Mukamal KJ, Ljung R, et al. Chocolate consumption and mortality following a first acute myocardial infarction. The Stockholm heart epidemiology program. J Intern Med. 2009;266:248-257.
6. Engler MB, Engler MM, Chen CY, et al. Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentration in healthy adults. J Am Coll Nutr. 2004;23:197-204.
7. Faridi Z, Njike VY, Dutta S, et al. Acute dark chocolate and cocoa ingestion and endothelial function: a randomized controlled crossover trial. Am J Clin Nutr. 2008;88:58-63.
8. Karim M, McCormick K, Kappagoda CT. Effects of cocoa extracts on endothelium-dependent relaxation. J Nutr. 2000;12(Suppl): S2105-S2108.
9. Heptinstall S, May J, Fox S, et al. Cocoa flavanols and platelet and leukocyte function: recent in vitro and in vivo studies in healthy adults. J Cardiovasc Pharmacol. 2006;47(Suppl 2):S197-S205.
10. Innes AJ, Kennedy G, McLaren M, et al. Dark chocolate inhibits platelet aggregation in healthy volunteers. Platelets. 2003;14:325-327.
11. Lee KW, Kim YJ, Lee HJ, et al. Cocoa has more phenolic phytochemicals and a higher antioxidant capacity than teas and red wine. J Agric Food Chem. 2003;51:7292-7295.
12. Fisher ND, Hughes M, Gerhard-Herman M, et al. Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans. J Hypertens. 2003;21:2281-2286.
13. Selmi C, Mao TK, Keen CL, et al. The anti-inflammatory properties of cocoa flavanols. Cardiovasc Pharmacol. 2006;47(Suppl 2):S163-S171.
14. Kondo K, Hirano R, Matsumoto A, et al. Inhibition of LDL oxidation by cocoa. Lancet. 1996;348:1514.
15. Pearson DA, Schmitz HH, Lazarus SA, et al. Inhibition of in vitro lowdensity lipoprotein oxidation by oligomeric procyanidins present in chocolate and cocoas. Methods Enzymol. 2001;335:350-360.
16. Aron PM, Kennedy JA. Flavan-3-ols: nature, occurrence and biological activity. Mol Nutr Food Res. 2008;52:79-104.
17. Keen CL, Holt RR, Oteiza PI, et al. Cocoa antioxidants and cardiovascular health. Am J Clin Nutr. 2005;81:S298-S303.
18. Kris-Etherton PM, Keen CL. Evidence that the antioxidant flavonoids in tea and cocoa are beneficial for cardiovascular health. Curr Opin Lipidol. 2002;13:41-49.
19. Kurosawa T, Itoh F, Nozaki A, et al. Suppressive effects of cacao liquor polyphenols (CLP) on LDL oxidation and the development of atherosclerosis in Kurosawa and Kusanagi-hypercholesterolemic rabbits. Atherosclerosis. 2005;179:237-246.
20. Grassi D, Necozione S, Lippi C, et al. Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension. 2005;46:398-405.
21. Ruiz-Ortega M, Lorenzo O, Rupérez M, et al. Role of the reninangiotensin system in vascular diseases: expanding the field. Hypertension. 2001;38:1382-1387.
22. Ackermann A, Fernàndez-Alfonso MS, Sànchez de Rojas R, et al. Modulation of angiotensin-converting enzyme by nitric oxide. Br J Pharmacol. 1998;124:291-298.
23. Persson K, Säfholm ACE, Andersson RGG, et al. Glyceryl trinitrateinduced angiotensin-converting enzyme (ACE) inhibition in healthy volunteers is dependent on ACE genotype. Can J Physiol Pharmacol. 2005;83:1117-1122.
24. Ono K, Takahashi T, Kamei M, et al. Effects of an aqueous extract of cocoa on nitric oxide production of macrophages activated by lipopolysaccharide and interferon-g. Nutrition. 2003;19:681-685.
25. Persson IA-L, Josefsson M, Persson K, et al. Tea flavanols inhibit angiotensin-converting enzyme activity and increase nitric oxide production in human endothelial cells. J Pharm Pharmacol. 2006;58: 1139-1144.
26. Persson IAL, Persson K, Hägg S, et al. Effects of green tea, black tea and Rooibos tea on angiotensin-converting enzyme and nitric oxide in healthy volunteers. Public Health Nutr. 2010;13:730-737.
27. Cheon KT, Choi KH, Lee HB, et al. Gene polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in patients with lung cancer. Lung. 2000;178:351-360.
28. Richelle M, Tavazzi I, Enslen M, et al. Plasma kinetics in man of epicatechin from black chocolate. Eur J Clin Nutr. 1999;53:22-26.
29. Abrams WB, Davies RO, Gomez HJ. Clinical pharmacology of enalapril. J Hypertens. 1984;2(Suppl 2):31-36.
30. Taubert D, Roesen R, Lehmann C, et al. Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide, a randomized controlled trial. JAMA. 2007;298:49-60.
31. Ried K, Frank OR, Stocks N. Dark chocolate or tomato extract for prehypertension: a randomized controlled trial. BMC Compl Alternat Med. 2009;9:22.
32. Hertog MG, Feskens EJ, Hollman PC, et al. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet. 1993;342:1007-1011.
33. Joshipura KJ, Ascherio A, Manson JE, et al. Fruit and vegetable intake in relation to risk of ischemic stroke. JAMA. 1999;282:1233-1239.
34. Keli SO, Hertog MG, Feskens EJ, et al. Dietary flavonoids, antioxidant vitamins, and incidence of stroke: the Zutphen study. Arch Intern Med. 1996;156:637-642.
35. Knekt P, Jarvinen R, Reunanen A, et al. Flavonoid intake and coronary mortality in Finland: a cohort study. Br Med J. 1996;312:478-481.
36. Nutrient Data Laboratory, Beltsville Human Nutrition Research Center, Agricultural Research Service, US Department of Agriculture. USDA database for the proanthocyanidin content of selected foods. http://www.nal.usda.gov/fnic/ foodcomp. Accessed October 6, 2009. 2004.
37. Sànchez-Rabaneda F, Jàuregui O, Casals I, et al. Liquid chromatographic/electrospray ionization tandem mass spectrometric study of the phenolic composition of cocoa (Theobroma cacao). JMass Spectrom. 2003;38:35-42.
38. Persson IA-L, Lindén E, Andersson M, et al. Effects of Ginkgo biloba extract EGb 761 and its terpene-lactones on angiotensin converting enzyme activity and nitric oxide production in human endothelial cells. Asian J Trad Med. 2008;3:42-51.
39. Hammerstone JF, Lazarus SA, Schmitz HH. Procyanidin content and variation in some commonly consumed foods. J Nutr. 2000;130(Suppl): S2086-S2092.
40. Miller NJ, Castelluccio C, Tijburg L, et al. The antioxidant properties of theaflavins and their gallate esters-radical scavengers or metal chelators? FEBS Lett. 1996;392:40-44.
41. Hider RC, Liu ZD, Khodr HH. Metal chelation of polyphenols. Methods Enzymol. 2001;335:190-203.
42. Danser AHJ, Batenburg WW, van den Meiracker AH, et al. ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition? Pharmacol Ther. 2007;113:607-618.
43. Heiss C, Schewe T, Kelm M. Vascular effects of cocoa rich in flavan-3-ols. JAMA. 2003:290:1030-1031.
44. Schnorr O, Brossette T, Momma TY, et al. Cocoa flavanols lower vascular arginase activity in human endothelial cells in vitro and in erythrocytes in vivo. Arch Biochem Biophys. 2008;476:211-215.
45. Ramirez-Sanchez I, Maya L, Ceballos G, et al. (2)-Epicatechin activation of endothelial cell endothelial nitric oxide synthase, nitric oxide, and related signaling pathways. Hypertension. 2010;55:1398-1405.
46. Schramm DD, Karim M, Schrader HR, et al. Food effects on the absorption and pharmacokinetics of cocoa flavanols. Life Sci. 2003;73: 857-869.